GENE ONLINE|News &
Opinion
Blog

BCMA
Kite And Arcellx Join Forces for Developing Cell Therapy targeting Multiple Myeloma
2022-12-12
J&J, Legend’s Cell Therapy Gets FDA Nod
2022-03-01
Bristol-Myers Squibb’s Abecma Becomes First Approved CAR T-Cell Therapy for Multiple Myeloma in Japan
2022-01-24
AbbVie to Acquire TeneoOne and Its Lead Multiple Myeloma Drug
2021-06-27
BMS, bluebird’s Multiple Myeloma Drug Becomes First BCMA Targeting CAR-T Therapy to Snag FDA Okay
2021-03-28
GSK’s anti-BCMA Therapy Notches FDA Approval for Refractory Multiple Myeloma
2020-08-09
Kite Pharma Licences Teneobio’s Antibody Platform to Fight Multiple Myeloma
2020-04-03
Tracking “OFF THE SHELF” CAR-T Cell therapy & an IPO worth $100M
2018-10-15
LATEST
West Nile and Usutu Viruses Detected in Wild Carnivore Populations in the Netherlands
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Biotech Stock Performance Gap Widens During Second Quarter of 2026
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
Penn State College of Medicine Receives $2.5 Million Grant for Street Medicine Program
2026-07-10
Scroll to Top